Edwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance

MT Newswires Live

Apr 24

Edwards Lifesciences (EW) reported Q1 adjusted earnings late Wednesday of $0.64, up from $0.55 a year earlier.

Analysts polled by FactSet expected $0.60.

Net sales for the quarter ended March 31 were $1.41 billion, up from $1.33 billion a year earlier.

Analysts polled by FactSet expected $1.40 billion.

The company said it expects Q2 adjusted EPS of $0.59 to $0.65 on sales of $1.45 billion to $1.53 billion. Analysts polled by FactSet project $0.62 and $1.46 billion, respectively.

For full-year 2025, Edwards reaffirmed adjusted EPS guidance of $2.40 to $2.50. The company said it raised sales guidance for the year to a range of $5.7 billion to $6.1 billion. Analysts polled by FactSet expect adjusted EPS of $2.46 on sales of $5.82 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2529669667"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529669667\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2529669667?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-24 05:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529669667","market":"hk","top_or_hot":-1,"title":"Edwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance","media":"MT Newswires Live","content":"<html><body><p> Edwards Lifesciences (EW) reported Q1 adjusted earnings late Wednesday of $0.64, up from $0.55 a year earlier.</p><p>Analysts polled by FactSet expected $0.60.</p><p>Net sales for the quarter ended March 31 were $1.41 billion, up from $1.33 billion a year earlier.</p><p>Analysts polled by FactSet expected $1.40 billion.</p><p>The company said it expects Q2 adjusted EPS of $0.59 to $0.65 on sales of $1.45 billion to $1.53 billion. Analysts polled by FactSet project $0.62 and $1.46 billion, respectively.</p><p>For full-year 2025, Edwards reaffirmed adjusted EPS guidance of $2.40 to $2.50. The company said it raised sales guidance for the year to a range of $5.7 billion to $6.1 billion. Analysts polled by FactSet expect adjusted EPS of $2.46 on sales of $5.82 billion.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Edwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEdwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-24 05:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Edwards Lifesciences (EW) reported Q1 adjusted earnings late Wednesday of $0.64, up from $0.55 a year earlier.</p><p>Analysts polled by FactSet expected $0.60.</p><p>Net sales for the quarter ended March 31 were $1.41 billion, up from $1.33 billion a year earlier.</p><p>Analysts polled by FactSet expected $1.40 billion.</p><p>The company said it expects Q2 adjusted EPS of $0.59 to $0.65 on sales of $1.45 billion to $1.53 billion. Analysts polled by FactSet project $0.62 and $1.46 billion, respectively.</p><p>For full-year 2025, Edwards reaffirmed adjusted EPS guidance of $2.40 to $2.50. The company said it raised sales guidance for the year to a range of $5.7 billion to $6.1 billion. Analysts polled by FactSet expect adjusted EPS of $2.46 on sales of $5.82 billion.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EW","symbol_name":"爱德华兹","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2529669667","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529669667","pubTimestamp":1745442858,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Edwards Lifesciences  reported Q1 adjusted earnings late Wednesday of $0.64, up from $0.55 a year earlier.Analysts polled by FactSet expected $0.60.Net sales for the quarter ended March 31 were $1.41 billion, up from $1.33 billion a year earlier.Analysts polled by FactSet expected $1.40 billion.The company said it expects Q2 adjusted EPS of $0.59 to $0.65 on sales of $1.45 billion to $1.53 billion. Analysts polled by FactSet project $0.62 and $1.46 billion, respectively.For full-year 2025, Edwards reaffirmed adjusted EPS guidance of $2.40 to $2.50. The company said it raised sales guidance for the year to a range of $5.7 billion to $6.1 billion. Analysts polled by FactSet expect adjusted EPS of $2.46 on sales of $5.82 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"EW":"爱德华兹"},"translate_title":"爱德华兹生命科学第一季度调整后盈利、销售额增长；提供第二季度指导","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EW":1},"content_text":"Edwards Lifesciences (EW) reported Q1 adjusted earnings late Wednesday of $0.64, up from $0.55 a year earlier.Analysts polled by FactSet expected $0.60.Net sales for the quarter ended March 31 were $1.41 billion, up from $1.33 billion a year earlier.Analysts polled by FactSet expected $1.40 billion.The company said it expects Q2 adjusted EPS of $0.59 to $0.65 on sales of $1.45 billion to $1.53 billion. Analysts polled by FactSet project $0.62 and $1.46 billion, respectively.For full-year 2025, Edwards reaffirmed adjusted EPS guidance of $2.40 to $2.50. The company said it raised sales guidance for the year to a range of $5.7 billion to $6.1 billion. Analysts polled by FactSet expect adjusted EPS of $2.46 on sales of $5.82 billion.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}